Idiopathic Pulmonary Fibrosis

An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management

Raghu, G., Collard, H. R., Egan, J. J., Martinez, F. J., Behr, J., Brown, K. K., Colby, T. V., Cordier, J.-F., Flaherty, K. R., Lasky, J. A., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2009-040gl · Cited by 7,186

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

Richeldi, L., du Bois, R. M., Raghu, G., Azuma, A., Brown, K. K., Costabel, U., Cottin, V., Flaherty, K. R., Hansell, D. M., Inoue, Y., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402584 · Cited by 4,654

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

King, T. E., Bradford, W. Z., Castro-Bernardini, S., Fagan, E. A., Glaspole, I., Glassberg, M. K., Gorina, E., Hopkins, P. M., Kardatzke, D., Lancaster, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402582 · Cited by 3,975

Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement

Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2013) · Annals of Internal Medicine · doi:10.7326/m13-2771 · Cited by 2,642

Guidelines for Management of Incidental Pulmonary Nodules Detected on CT Images: From the Fleischner Society 2017.

MacMahon, H., Naidich, D. P., Goo, J. M., Lee, K. S., Leung, A. N. C., Mayo, J. R., Mehta, A. C., Ohno, Y., Powell, C. A., Prokop, M., et al. (2017) · Radiology · doi:10.1148/radiol.2017161659 · Cited by 2,491

An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: An Update of the 2011 Clinical Practice Guideline

Raghu, G., Rochwerg, B., Zhang, Y., Garcia, C. A. C., Azuma, A., Behr, J., Brozek, J. L., Collard, H. R., Cunningham, W., Homma, S., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201506-1063st · Cited by 1,916

Prednisone, Azathioprine, and N -Acetylcysteine for Pulmonary Fibrosis

The Idiopathic Pulmonary Fibrosis Clinical Research Network (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113354 · Cited by 1,654

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report

Collard, H. R., Ryerson, C. J., Corte, T. J., Jenkins, G., Kondoh, Y., Lederer, D. J., Lee, J. S., Maher, T. M., Wells, A. U., Antoniou, K. M., et al. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201604-0801ci · Cited by 1,444

Telomerase Mutations in Families with Idiopathic Pulmonary Fibrosis

Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357

A consensus document for the selection of lung transplant candidates: 2014–an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation

Weill, D., Benden, C., Corris, P. A., Dark, J. H., Davis, R. D., Keshavjee, S., Lederer, D. J., Mulligan, M. J., Patterson, G. A., Singer, L. G., et al. (2015) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2014.06.014 · Cited by 1,329

Endothelial Colony-Forming Cells Do Not Participate to Fibrogenesis in a Bleomycin-Induced Pulmonary Fibrosis Model in Nude Mice

Blandinières, A., Gille, T., Sadoine, J., Bièche, I., Slimani, L., Dizier, B., Gaussem, P., Chaussain, C., Planès, C., Dorfmüller, P., et al. (2018) · Stem Cell Reviews and Reports · doi:10.1007/s12015-018-9846-5 · Cited by 15

The Value of the Surprise Question to Predict One-Year Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Cohort Study

Moor, C. C., Tak, N. C., Owusuaa, C., Miedema, J., Baart, S. J., van der Rijt, C. C. D., & Wijsenbeek, M. S. (2021) · Respiration · doi:10.1159/000516291 · Cited by 16

Adipose Stromal Cell-Secretome Counteracts Profibrotic Signals From IPF Lung Matrices

Vasse, G. F., van Os, L., Jager, M. D., Jonker, M. R., Borghuis, T., Toorn, L. T. V. D., Jellema, P. G., White, E. S., van Rijn, P., Harmsen, M. C., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.669037 · Cited by 15

A Handcrafted Radiomics-Based Model for the Diagnosis of Usual Interstitial Pneumonia in Patients with Idiopathic Pulmonary Fibrosis

Refaee, T., Bondue, B., Simaeys, G. V., Wu, G., Yan, C., Woodruff, H. C., Goldman, S., & Lambin, P. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12030373 · Cited by 15

Insights gained in the pathology of lung disease through single‐cell transcriptomics

Carraro, G., & Stripp, B. R. (2022) · The Journal of Pathology · doi:10.1002/path.5971 · Cited by 15

The Association between Exposures and Disease Characteristics in Familial Pulmonary Fibrosis

Copeland, C. R., Donnelly, E. F., Mehrad, M., Ding, G., Markin, C. R., Douglas, K., Wu, P., Cogan, J. D., Young, L. R., Bartholmai, B. J., et al. (2022) · Annals of the American Thoracic Society · doi:10.1513/annalsats.202203-267oc · Cited by 15

Pharmacological Activities of Ginkgolic Acids in Relation to Autophagy

Ding, Y. F., Ding, Z., Xu, J., Li, Y., & Chen, M. (2022) · Pharmaceuticals · doi:10.3390/ph15121469 · Cited by 15

Stereotactic ablative radiotherapy in patients with early-stage non-small cell lung cancer and co-existing interstitial lung disease

Finazzi, T., Ronden, M., Spoelstra, F. O. B., Nossent, E. J., Nijman, S. F. M., Bahce, I., Dickhoff, C., & Senan, S. (2020) · Acta Oncologica · doi:10.1080/0284186x.2020.1730002 · Cited by 15

Sensitive cluster-free differential expression testing.Preprint

Missarova, A. M., Rosen, L. U., Dann, E., Satija, R., & Marioni, J. C. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.08.531744 · Cited by 15

The lung microbiome in interstitial lung disease

Mikhail, S. G., & O’Dwyer, D. N. (2025) · Breathe · doi:10.1183/20734735.0167-2024 · Cited by 17

Licochalcone B attenuates pulmonary fibrosis via inhibiting ZBP1-dependent PANoptosis

Ren, H. W., Zhao, C., Zhou, L., Ke, Q., Chen, Y., Chen, Z., He, J., Chen, D., He, X., Quan, M., et al. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.119940 · Cited by 14

Breaking the cycle: should we target inflammation, fibrosis, or both?

Baxter, S. K., Irizarry-Caro, R. A., Heiden, J. A. V., & Arron, J. R. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1569501 · Cited by 15

Development of a Green and Sustainable Manufacturing Process for Gefapixant Citrate (MK-7264) Part 3: Development of a One-Pot Formylation–Cyclization Sequence to the Diaminopyrimidine Core

Basu, K., Lehnherr, D., Martin, G. E., Desmond, R. A., Lam, Y., Peng, F., Chung, J. Y. L., Arvary, R. A., Zompa, M. A., Zhang, S.-W., et al. (2020) · Organic Process Research & Development · doi:10.1021/acs.oprd.0c00246 · Cited by 14

A model of the aged lung epithelium in idiopathic pulmonary fibrosis

Shaghaghi, H., Cuevas-Mora, K., Para, R., Tran, C., Roque, W., Robertson, M. J., Rosas, I. O., Summer, R. S., & Romero, F. (2021) · Aging · doi:10.18632/aging.203291 · Cited by 14

HuR drives lung fibroblast differentiation but not metabolic reprogramming in response to TGF-β and hypoxia

Trivlidis, J., Aloufi, N., Al‐Habeeb, F., Nair, P. K., Azuelos, I., Eidelman, D. H., & Baglole, C. J. (2021) · Respiratory Research · doi:10.1186/s12931-021-01916-4 · Cited by 14

Development and validation of the prognostic model based on autophagy-associated genes in idiopathic pulmonary fibrosis

Fan, G., Liu, J., Wu, Z. S., Li, C., & Zhang, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1049361 · Cited by 15

Bu-Fei-Huo-Xue capsule alleviates bleomycin-induced pulmonary fibrosis in mice through modulating gut microbiota

Hu, H., Wang, F., Han, P., Li, P., Wang, K., Song, H., Zhao, G., Li, Y., Lu, X., Tao, W., et al. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1084617 · Cited by 16

Fibroblast-derived Extracellular Vesicles Induce Lung Cancer Progression in the Idiopathic Pulmonary Fibrosis Microenvironment

Fujita, Y., Fujimoto, S., Miyamoto, A., Kaneko, R., Kadota, T., Watanabe, N., Kizawa, R., Kawamoto, H., Watanabe, J. A., Utsumi, H., et al. (2023) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2022-0253oc · Cited by 21

Efficient transfected liposomes co-loaded with pNrf2 and pirfenidone improves safe delivery for enhanced pulmonary fibrosis reversion

Chang, X. Y., Liu, C., Han, Y., Li, Q., Guo, B., & Jiang, H. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.04.006 · Cited by 14

Enfermedades Respiratorias del Siglo XXI

Vallejo-López, A. B., Amaya, J. E. R., Kou-Guzmán, J., Aguagallo, F. R. V., & Moran, L. D. R. (2023) · Editorial Grupo AEA eBooks · doi:10.55813/egaea.l.2022.36 · Cited by 14

Genistein alleviates pulmonary fibrosis by inactivating lung fibroblasts

Kwon, S., Chung, H., Seo, J.-W., & Kim, H. S. (2023) · BMB Reports · doi:10.5483/bmbrep.2023-0099 · Cited by 14

Catch your breath: The protective role of the angiotensin AT2 receptor for the treatment of idiopathic pulmonary fibrosis

Young, O. N., Bourke, J. E., & Widdop, R. E. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115839 · Cited by 16

Idiopathic pulmonary fibrosis: Pathophysiology, cellular signaling, diagnostic and therapeutic approaches

Shakeel, I., Afzal, M., Islam, A., Sohal, S. S., & Hassan, M. I. (2023) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2023.100167 · Cited by 15

Progressive Pulmonary Fibrosis: Where Are We Now?

Kang, H. K., & Song, J. W. (2023) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2023.0119 · Cited by 17

Pro-Fibrotic Effects of CCL18 on Human Lung Fibroblasts Are Mediated via CCR6

Höhne, K., Wagenknecht, A., Maier, C., Engelhard, P., Goldmann, T., Schließmann, S. J., Plönes, T., Trepel, M., Eibel, H., Müller–Quernheim, J., et al. (2024) · Cells · doi:10.3390/cells13030238 · Cited by 13

Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis

Kulkarni, T., Criner, G. J., Kass, D. J., Rosas, I. O., Scholand, M. B., Dilling, D. F., Summer, R. S., & Duncan, S. R. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-02957-3 · Cited by 15

Effects of Anti-Fibrotic Drugs on Transcriptome of Peripheral Blood Mononuclear Cells in Idiopathic Pulmonary Fibrosis

Ishii, D., Kawasaki, T., Sato, H., Tatsumi, K., Imamoto, T., Yoshioka, K., Abe, M., Hasegawa, Y., Ohara, O., & Suzuki, T. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073750 · Cited by 14

Oxygen therapy for exercise capacity in fibrotic interstitial lung disease: A systematic review and meta-analysis of randomised controlled trials

Lin, L., Wu, Y.-C., Wu, J.-J., Tai, H.-Y., Huang, T., & Cheng, W.-H. (2024) · Respiratory Medicine · doi:10.1016/j.rmed.2024.107657 · Cited by 15

Advanced Delivery Strategies of Nintedanib for Lung Disorders and Beyond: A Comprehensive Review

Thakkar, D., Singh, S., & Wairkar, S. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02869-9 · Cited by 15

N‐Phenyl‐2‐Pyridone‐Derived Endoperoxide Suppressing both Lung Cancer and Idiopathic Pulmonary Fibrosis Progression by Three‐Pronged Action**

Wang, L., Wu, H., Liu, Z., Sun, R., Li, Y., Si, Y., Nie, Y., Yuan, Q., Qian, X., Zhang, S., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202408473 · Cited by 14

Biomimetic Topological Micropattern Arrays Regulate the Heterogeneity of Cellular Fates in Lung Fibroblasts between Fibrosis and Invasion

Zhu, X., Mao, S., Yang, Y. K., Liu, X., Liu, Q., Zhang, N., Yang, Y., Li, Y., Gao, M., Bao, J., et al. (2025) · ACS Nano · doi:10.1021/acsnano.4c11113 · Cited by 14

Ferroptosis in organ fibrosis: Mechanisms and therapeutic approaches

Ning, Z.-H., Wang, X., Zhao, Y., Ou, Y., Yang, J., Tang, H., & Hu, H.-J. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114341 · Cited by 14

eNAMPT Is a Novel DAMP and Therapeutic Target in Human and Murine Pulmonary Fibrosis

Casanova, N. G., Herazo‐Maya, J. D., Kempf, C. L., Sun, B. L., Song, J. H., Hernandez, A., Galaviz, J. C., Sun, X., Camp, S. M., Ledford, J. G., et al. (2025) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2024-0342oc · Cited by 16

A comprehensive and practical approach to the management of idiopathic pulmonary fibrosis

Moran‐Mendoza, O., Colman, R., Kalluri, M., Cabalteja, C., & Harle, I. A. (2019) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2019.1627204 · Cited by 15

Regional distribution of high-attenuation areas on chest computed tomography in the Multi-Ethnic Study of Atherosclerosis

Choi, B., Kawut, S. M., Raghu, G., Hoffman, E. A., Tracy, R. P., Madahar, P., Bernstein, E. J., Barr, R. G., Lederer, D. J., & Podolanczuk, A. J. (2020) · ERJ Open Research · doi:10.1183/23120541.00115-2019 · Cited by 14

Subclinical liver fibrosis in patients with idiopathic pulmonary fibrosis

Cocconcelli, E., Tonelli, R., Abbati, G., Marchioni, A., Castaniere, I., Pelizzaro, F., Russo, F. P., Vegetti, A., Balestro, E., Pietrangelo, A., et al. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02376-2 · Cited by 15

Maimendong Decoction Improves Pulmonary Function in Rats With Idiopathic Pulmonary Fibrosis by Inhibiting Endoplasmic Reticulum Stress in AECIIs

Shen, M., Nan, Y., Zhang, L. H., Di, L., He, S., Li, Y., & Li, Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.01262 · Cited by 14

Spliceosome-associated protein 130: a novel biomarker for idiopathic pulmonary fibrosis

Liu, K., Liu, D., Feng, Y., Zhang, H., Zeng, D., Liu, Q., & Qu, J. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-4404 · Cited by 14

Healthcare use and costs among Medicare enrollees on pirfenidone versus nintedanib for idiopathic pulmonary fibrosis

Corral, M., Chang, E. Y., Broder, M. S., Gokhale, S., & Reddy, S. R. (2020) · Journal of Comparative Effectiveness Research · doi:10.2217/cer-2020-0084 · Cited by 14

Construction and validation of a bronchoalveolar lavage cell-associated gene signature for prognosis prediction in idiopathic pulmonary fibrosis

Xia, Y., Lei, C., Yang, D., & Luo, H. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2021.107369 · Cited by 14

Anti-Fibrotic Effects of Low Toxic Microcystin-RR on Bleomycin-Induced Pulmonary Fibrosis: A Comparison with Microcystin-LR

Wang, J., Ren, Y., Zheng, X., Kang, J., Huang, Z., Xu, L., & Wang, Y. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.675907 · Cited by 13

All-cause mortality of patients with idiopathic pulmonary fibrosis: a nationwide population-based cohort study in Korea

Ko, S. J., Choi, S. M., Han, K., Lee, C., & Lee, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-94655-x · Cited by 16

Management of patients with fibrosing interstitial lung diseases

Morrow, L. E., Hilleman, D. E., & Malesker, M. A. (2021) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxab375 · Cited by 14

The Multi-Faceted Extracellular Matrix: Unlocking Its Secrets for Understanding the Perpetuation of Lung Fibrosis

Nizamoglu, M., & Burgess, J. K. (2021) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-021-00031-2 · Cited by 15

Wenfei Buqi Tongluo Formula Against Bleomycin-Induced Pulmonary Fibrosis by Inhibiting TGF-β/Smad3 Pathway

Ding, L., Li, Y., Yang, Y., Song, S., Qi, H., Wang, J., Wang, Z., Zhao, J., Zhang, W., Zhao, D., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.762998 · Cited by 14

Integrated RNA-sequencing and network pharmacology approach reveals the protection of Yiqi Huoxue formula against idiopathic pulmonary fibrosis by interfering with core transcription factors

Li, H., Zhao, C., Muhetaer, G., Guo, L., Yao, K., Zhang, G., Ji, Y., Xing, S., Zhou, J., & Huang, X. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154301 · Cited by 15

Entrectinib ameliorates bleomycin-induced pulmonary fibrosis in mice by inhibiting TGF-β1 signaling pathway

Miao, Y., Li, X., Yang, Y., Zhang, J., Chen, L., Zhang, Q., Li, W., Liu, Y., Zhang, X., Gu, R., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109427 · Cited by 14

Epigenetics Approaches toward Precision Medicine for Idiopathic Pulmonary Fibrosis: Focus on DNA Methylation

Effendi, W. I., & Nagano, T. (2023) · Biomedicines · doi:10.3390/biomedicines11041047 · Cited by 15

Schädigungsmuster interstitieller Lungenerkrankungen

Länger, F. P., Stark, H., Braubach, P., Ackermann, M., Hussein, K., Teiken, K., Maegel, L., Kühnel, M., & Jonigk, D. D. (2018) · Der Pathologe · doi:10.1007/s00292-018-0503-1 · Cited by 14

Remarkable Improvement in a Patient with Idiopathic Pulmonary Fibrosis after Treatment with Nintedanib

Nakano, A., Ohkubo, H., Fukumitsu, K., Fukuda, S., Kanemitsu, Y., Takemura, M., Maeno, K., Ito, Y., Oguri, T., & Niimi, A. (2018) · Internal Medicine · doi:10.2169/internalmedicine.1890-18 · Cited by 15

Epithelial Alarmins in Serum and Exhaled Breath in Patients with Idiopathic Pulmonary Fibrosis: A Prospective One-Year Follow-Up Cohort Study

Majewski, S., Szewczyk, K., Białas, A. J., Miłkowska-Dymanowska, J., Górski, P., & Piotrowski, W. J. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8101590 · Cited by 14

Synthesis and discovery of new compounds bearing coumarin scaffold for the treatment of pulmonary fibrosis

Deng, D., Pei, H., Lan, T., Zhu, J., Tang, M., Xue, L., Yang, Z., Zheng, S., Ye, H., & Chen, L. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111790 · Cited by 14

Insights Into Development and Progression of Idiopathic Pulmonary Fibrosis From Single Cell RNA Studies

Németh, J., Schundner, A., & Frick, M. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.611728 · Cited by 17

Mosaic loss of chromosome Y in blood is associated with male susceptibility for idiopathic pulmonary fibrosis

Bjurling, J., Chavkin, N. W., Halvardson, J., Thel, M. C., Mattisson, J., Kim, J. S., Zaghlool, A., Ma, S., Martínez, F. J., Anstrom, K. J., et al. (2025) · Communications Medicine · doi:10.1038/s43856-025-00966-9 · Cited by 13

Pulmonary surfactant-based pirfenidone-loaded nanovesicles for inhalation therapy of idiopathic pulmonary fibrosis

Kim, C. G., Jang, M., Oh, C., Jeon, O. H., Choi, B. H., Kim, K., Park, J., & Kim, H. K. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114005 · Cited by 13

The CCL20–integrin α5β1 interaction enhances TGF-β/Smad signaling to promote fibroblast activation in pulmonary fibrosis

Liu, S., Wang, Q., Min, J., Zhang, Y., Zhang, Y., Yang, J., Tan, Y., Tan, L., Yin, M., Zhang, Y., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-64211-6 · Cited by 15

Nintedanib Regulates GRK2 and CXCR2 to Reduce Neutrophil Recruitment in Endotoxin-Induced Lung Injury

Su, V. Y., Chen, W., Yu, W.-K., Wu, H.-H., Chen, H., & Yang, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22189898 · Cited by 13

La fibrose pulmonaire idiopathique

Hennion, N., Desseyn, J., Gottrand, F., Wémeau-Stervinou, L., & Gouyer, V. (2022) · médecine/sciences · doi:10.1051/medsci/2022084 · Cited by 15

Panax Notoginseng Saponins Regulate Transforming Growth Factor-β1 through MAPK and Snail/TWIST1 Signaling Pathway to Inhibit Epithelial-Mesenchymal Transition of Pulmonary Fibrosis in A549 Cells

Nguyen, V., Pan, F., Zhang, G., Zhang, Q., & Lu, Y. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/3744618 · Cited by 13

Clinical, imaging, and blood biomarkers to assess 1-year progression risk in fibrotic interstitial lung diseases—Development and validation of the honeycombing, traction bronchiectasis, and monocyte (HTM)-score

Shao, G., Hawle, P., Akbari, K., Horner, A., Hintenberger, R., Kaiser, B., Lamprecht, B., & Lang, D. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1043720 · Cited by 13

Lung Damage in Rheumatoid Arthritis—A Retrospective Study

Dinache, G., Popescu, C. C., Mogoşan, C., Enache, L., Agache, M., & Codreanu, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms24010028 · Cited by 13

Activating Protein-1 (AP-1): A Promising Target for the Treatment of Fibrotic Diseases

Pi, Z., Qiu, X., Liu, J., Shi, Y., Zeng, Z., & Xiao, R. (2023) · Current Medicinal Chemistry · doi:10.2174/0929867330666230209100059 · Cited by 13

Soluble E‐cadherin participates in BLM ‐induced pulmonary fibrosis by promoting EMT and lung fibroblast migration

Huang, C., Liang, C., Tong, J., Zhong, X., Luo, L., Liang, L.-P., Wen, Y., Zhong, L., Deng, J., Peng, M., et al. (2023) · Environmental Toxicology · doi:10.1002/tox.23986 · Cited by 13

Ablation of Stage I–II Non–Small Cell Lung Cancer in Patients With Interstitial Lung Disease: A Multicenter Retrospective Study

Fintelmann, F. J., Graur, A., Oueidat, K., Simon, J., Barnes, J. M. H., McDermott, S., Genshaft, S. J., Healey, T. T., Suh, R. D., Maxwell, A. W. P., et al. (2023) · American Journal of Roentgenology · doi:10.2214/ajr.23.30300 · Cited by 13

The Plastic Interplay between Lung Regeneration Phenomena and Fibrotic Evolution: Current Challenges and Novel Therapeutic Perspectives

Lettieri, S., Bertuccio, F. R., Frate, L. D., Perrotta, F., Corsico, A. G., & Stella, G. M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010547 · Cited by 14

PM 10 increases mortality risk in rheumatoid arthritis-associated interstitial lung disease

Kim, S. H., Kim, S., Yoon, H., & Song, J. W. (2024) · RMD Open · doi:10.1136/rmdopen-2023-003680 · Cited by 13

Evaluating the diagnostic and therapeutic significance of KL-6 in patients with interstitial lung diseases

Wang, T., Yao, Y., Wang, Y., Wei, W., Yin, B., Huang, M., Yuan, P., Chen, R., Wang, F., Wu, S., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e27561 · Cited by 13

Revolutionizing the Treatment of Idiopathic Pulmonary Fibrosis: From Conventional Therapies to Advanced Drug Delivery Systems

Singh, S., & Wairkar, S. (2024) · AAPS PharmSciTech · doi:10.1208/s12249-024-02793-y · Cited by 14

Supramolecular Nanofibers Ameliorate Bleomycin‐Induced Pulmonary Fibrosis by Restoring Autophagy

Zheng, D., Guo, J., Liang, Z., Jin, Y., Ding, Y., Liu, J., Qi, C., Shi, K., Xie, L., Zhu, M., et al. (2024) · Advanced Science · doi:10.1002/advs.202401327 · Cited by 12

Trigonelline hydrochloride attenuates silica-induced pulmonary fibrosis by orchestrating fibroblast to myofibroblast differentiation

Zhang, F., Yue, H., Dong, R., He, J., Zhou, L., Dou, X., Wang, L., Zheng, P., Mao, Z., Zhu, X., et al. (2024) · Respiratory Research · doi:10.1186/s12931-024-02876-1 · Cited by 13

SCARF2 is a target for chronic obstructive pulmonary disease: Evidence from multi‐omics research and cohort validation

Wang, S., Yue, Y., Wang, X., Tan, Y., & Zhang, Q. (2024) · Aging Cell · doi:10.1111/acel.14266 · Cited by 12

Chlorquinaldol Alleviates Lung Fibrosis in Mice by Inhibiting Fibroblast Activation through Targeting Methionine Synthase Reductase

Yang, X., Lin, G., Chen, Y., Lei, X., Ou, Y., Yan, Y., Wu, R., Yang, J., Luo, Y., Zhao, L., et al. (2024) · ACS Central Science · doi:10.1021/acscentsci.4c00798 · Cited by 13

Targeting the PI3K/mTOR pathway in idiopathic pulmonary fibrosis: Advances and therapeutic potential

Wang, Z., Guo, Y., Li, K., Huo, Y., Wang, S., Dong, S., & Ma, M. (2024) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2024.117908 · Cited by 13

CD8+ tissue-resident memory T cells are essential in bleomycin-induced pulmonary fibrosis

Feng, X. M., Yu, F., He, X., Cheng, P., Niu, Q., Zhao, L., Li, Q., Cui, X.-L., Jia, Z.-H., Ye, S.-Y., et al. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00368.2024 · Cited by 14

Cepharanthine attenuates pulmonary fibrosis via modulating macrophage M2 polarization

Bao, J., Liu, C. X., Song, H., Mao, Z., Qu, W., Yu, F., Shen, Y., Jiang, J., Chen, X., Wang, R., et al. (2024) · BMC Pulmonary Medicine · doi:10.1186/s12890-024-03250-z · Cited by 13

Computed tomography morphological assessments of central airways in interstitial lung abnormalities and idiopathic pulmonary fibrosis

Maetani, T., Tanabe, N., Tanizawa, K., Sakamoto, R., Shiraishi, Y., Hayashi, Y., Uyama, M., Matsunashi, A., Satô, S., Suzuki, K., et al. (2024) · Respiratory Research · doi:10.1186/s12931-024-03032-5 · Cited by 13

YouTube as a source of patient education in idiopathic pulmonary fibrosis: a media content analysis

Lashari, B. H., Chan, V., Shoukat, U., Arslan, A., Barry, H., Raza, A., & Patel, R. (2019) · Journal of Community Hospital Internal Medicine Perspectives · doi:10.1080/20009666.2019.1593779 · Cited by 13

Drug discovery and development in idiopathic pulmonary fibrosis: challenges and opportunities

Cruwys, S., Hein, P., Humphries, B., & Black, D. (2020) · Drug Discovery Today · doi:10.1016/j.drudis.2020.09.019 · Cited by 14

FK506-Binding Protein 13 Expression is Upregulated in Interstitial Lung Disease and Correlated with Clinical Severity. A Potentially Protective Role

Tat, V., Ayaub, E. A., Ayoub, A., Vierhout, M., Naiel, S., Padwal, M., Abed, S., Mekhael, O., Tandon, K., Revill, S. D., et al. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2020-0121oc · Cited by 13

Diagnosis Yield and Safety of Surgical Biopsy in Interstitial Lung Diseases: A Prospective Study

Radu, D. M., Freynet, O., Kambouchner, M., Boubaya, M., Nunès, H., Uzunhan, Y., Brillet, P., Guiraudet, P., Noorah, M. Z., Israël‐Biet, D., et al. (2021) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2021.08.056 · Cited by 13

The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease

Knudsen, K. S., Lehmann, S., Nielsen, R., Tangedal, S., Haaland, I., Hiemstra, P. S., & Eagan, T. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262082 · Cited by 13

Identification of Hub Genes in Idiopathic Pulmonary Fibrosis and NSCLC Progression:Evidence From Bioinformatics Analysis

Yao, Y., Li, Z., & Gao, W. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.855789 · Cited by 13

Development and Validation of a Novel Gene Signature for Predicting the Prognosis of Idiopathic Pulmonary Fibrosis Based on Three Epithelial-Mesenchymal Transition and Immune-Related Genes

Zheng, J., Dong, H., Zhang, T., Ning, J., Xu, Y., & Cai, C. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.865052 · Cited by 13

The Vasculature in Pulmonary Fibrosis

Engelbrecht, E., Kooistra, T., & Knipe, R. S. (2022) · Current Tissue Microenvironment Reports · doi:10.1007/s43152-022-00040-9 · Cited by 14

Fatty acid metabolism-related genes in bronchoalveolar lavage fluid unveil prognostic and immune infiltration in idiopathic pulmonary fibrosis

Lyu, Y., Chen, G., & Zhang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1001563 · Cited by 13

Guidelines of the Polish Respiratory Society on the Diagnosis and Treatment of Progressive Fibrosing Interstitial Lung Diseases Other than Idiopathic Pulmonary Fibrosis

Piotrowski, W. J., Martusewicz-Boros, M. M., Białas, A. J., Barczyk, A., Batko, B. P., Błasińska, K., Boros, P. W., Górska, K., Grzanka, P., Jassem, E., et al. (2022) · Advances in respiratory medicine · doi:10.3390/arm90050052 · Cited by 13

The lymphocyte-specific protein tyrosine kinase-specific inhibitor A-770041 attenuates lung fibrosis via the suppression of TGF-β production in regulatory T-cells

Kagawa, K., Sato, S., Koyama, K., Imakura, T., Murakami, K., Yamashita, Y., Naito, N., Ogawa, H., Kawano, H., & Nishioka, Y. (2022) · PLoS ONE · doi:10.1371/journal.pone.0275987 · Cited by 14

Design, synthesis and biological evaluation of novel diarylacylhydrazones derivatives for the efficient treatment of idiopathic pulmonary fibrosis

Su, X., Tan, Z., Wang, G., Liu, Z., Gan, C., Yue, L., Liu, H., Xie, Y., Yao, Y., & Ye, T. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114918 · Cited by 13

Dach1 deficiency drives alveolar epithelium apoptosis in pulmonary fibrosis via modulating C-Jun/Bim activity

Lu, Y., Tang, K., Wang, S., Tian, Z., Fan, Y., Li, B., Wang, M., Zhao, J., & Xie, J. (2023) · Translational research · doi:10.1016/j.trsl.2023.01.006 · Cited by 13

Deconvolution of RNA-Seq Analysis of Hyperbaric Oxygen-Treated Mice Lungs Reveals Mesenchymal Cell Subtype Changes

Yuan, Y., Zhou, Y., Li, Y., Hill, C. N., Ewing, R. M., Jones, M. G., Davies, D. E., Jiang, Z., & Wang, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041371 · Cited by 13

An information-theoretic approach for measuring the distance of organ tissue samples using their transcriptomic signatures

Manatakis, D. V., VanDevender, A. P., & Manolakos, E. S. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa654 · Cited by 13

Inhibition of the SET8 Pathway Ameliorates Lung Fibrosis Even Through Fibroblast Dedifferentiation

Ugai, K., Matsuda, S., Mikami, H., Shimada, A., Misawa, T., Nakamura, H., Tatsumi, K., Hatano, M., Murayama, T., & Kasuya, Y. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00192 · Cited by 13

Integrative Analysis of Transcriptome-Wide Association Study and mRNA Expression Profiles Identifies Candidate Genes Associated With Idiopathic Pulmonary Fibrosis

Gong, W., Guo, P., Liu, L., Guan, Q., & Yuan, Z. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.604324 · Cited by 13

Clinical Significance of Cold-Inducible RNA-Binding Protein in Idiopathic Pulmonary Fibrosis

Hozumi, H., Kataoka, K., Kondoh, Y., Isayama, T., Okada, J., Sugiura, K., Mori, K., Kono, M., Suzuki, Y., Karayama, M., et al. (2021) · CHEST Journal · doi:10.1016/j.chest.2021.06.067 · Cited by 14

Arsenic trioxide inhibits the functions of lung fibroblasts derived from patients with idiopathic pulmonary fibrosis

Joannes, A., Morzadec, C., Duclos, M., Gutierrez, F. L., Chiforeanu, D. C., Naourès, C. L., Latour, B. R. D., Rouzé, S., Wollin, L., Jouneau, S., et al. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.115972 · Cited by 13

Telomeropathy in Chronic Hypersensitivity Pneumonitis

Bouros, D. E., & Tzouvelekis, A. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201907-1483ed · Cited by 13

Extracellular Vesicles in Idiopathic Pulmonary Fibrosis: Pathogenesis, Biomarkers and Innovative Therapeutic Strategies

Yang, Y., Lv, M., Xu, Q., Wang, X., & Fang, Z.-J. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s491335 · Cited by 14

From Epithelium to Therapy: Transitional Cells in Lung Fibrosis

Shin, S. Y., Chen, J., Krentsis, I. M., Reisner, Y., Abrencillo, R., Hussain, R., Wu, D., & Karmouty‐Quintana, H. (2024) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2024-0372tr · Cited by 15

Associations of interstitial lung disease subtype and CT pattern with lung function and survival

Kim, J. S., Pugashetti, J. V., Ma, S., Huang, Y., Podolanczuk, A. J., Lynch, D. A., Oh, A. S., Mychaleckyj, J. C., Manichaikul, A. W., Rich, S. S., et al. (2025) · Thorax · doi:10.1136/thorax-2024-222149 · Cited by 15

A Trans-Agency Workshop on the Pathophysiology of Radiation-Induced Lung Injury

Cassatt, D. R., Gorovets, A., Karimi-Shah, B. A., Roberts, R., Price, P. W., Satyamitra, M. M., Todd, N. F., Wang, S., & Marzella, L. (2021) · Radiation Research · doi:10.1667/rade-21-00127.1 · Cited by 12

Update on diagnosis and treatment of idiopathic pulmonary fibrosis

Martínez, J. A. B., Baldi, B. G., da Costa, C. H., Jezler, S. F. D. O., Lima, M. S., & Rufino, R. (2015) · Jornal Brasileiro de Pneumologia · doi:10.1590/s1806-37132015000000152 · Cited by 39

Idiopathic pulmonary fibrosis: an Australian perspective

Prasad, J. D., Holland, A. E., Glaspole, I., & Westall, G. P. (2016) · Internal Medicine Journal · doi:10.1111/imj.13078 · Cited by 10

Management of Idiopathic Pulmonary Fibrosis

Fioret, D., Roman, J., & Perez, R. L. (2011) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e31821fbdbc · Cited by 10

Lung transplantation for idiopathic pulmonary fibrosis

Pavec, J. L., Dauriat, G., Gazengel, P., Dolidon, S., Hanna, A., Feuillet, S., Pradère, P., Crutu, A., Florea, V., Boulate, D., et al. (2020) · La Presse Médicale · doi:10.1016/j.lpm.2020.104026 · Cited by 29

[Diagnostic criteria and possible treatment of idiopathic pulmonary fibrosis].

Bendstrup, E. M., Hyldgaard, C., & Hilberg, O. (2014) · PubMed · Cited by 2